Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2026-01-24 @ 3:44 AM
Study NCT ID:
NCT04049266
Status:
TERMINATED
Last Update Posted:
2024-07-18
First Post:
2019-08-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
Sponsor:
Kodiak Sciences Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KSI-CL-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None